These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38742901)

  • 21. Determination of the P1', P2' and P3' subsite-specificity of factor Xa.
    Ludeman JP; Pike RN; Bromfield KM; Duggan PJ; Cianci J; Le Bonniec B; Whisstock JC; Bottomley SP
    Int J Biochem Cell Biol; 2003 Feb; 35(2):221-5. PubMed ID: 12479872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease.
    MacDonald EA; Frey G; Namchuk MN; Harrison SC; Hinshaw SM; Windsor IW
    ACS Infect Dis; 2021 Sep; 7(9):2591-2595. PubMed ID: 34437808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 3CL
    Kuo CJ; Liang PH
    FEBS Lett; 2022 May; 596(9):1214-1224. PubMed ID: 35302661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor.
    Lazure C; Gauthier D; Jean F; Boudreault A; Seidah NG; Bennett HP; Hendy GN
    J Biol Chem; 1998 Apr; 273(15):8572-80. PubMed ID: 9535830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL
    Rawson JMO; Duchon A; Nikolaitchik OA; Pathak VK; Hu WS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.
    Ahmad B; Batool M; Ain QU; Kim MS; Choi S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
    Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    Angew Chem Int Ed Engl; 2021 Dec; 60(49):25933-25941. PubMed ID: 34581471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.
    Chiou WC; Hsu MS; Chen YT; Yang JM; Tsay YG; Huang HC; Huang C
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):147-153. PubMed ID: 33430659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
    Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
    Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate specificity of cucumisin on synthetic peptides.
    Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL
    Ma L; Xie Y; Zhu M; Yi D; Zhao J; Guo S; Zhang Y; Wang J; Li Q; Wang Y; Cen S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
    Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
    J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.
    Bristol JA; Furie BC; Furie B
    J Biol Chem; 1993 Apr; 268(10):7577-84. PubMed ID: 8463288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.
    Manelfi C; Gossen J; Gervasoni S; Talarico C; Albani S; Philipp BJ; Musiani F; Vistoli G; Rossetti G; Beccari AR; Pedretti A
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33557115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
    Beyer BB; Johnson JV; Chung AY; Li T; Madabushi A; Agbandje-McKenna M; McKenna R; Dame JB; Dunn BM
    Biochemistry; 2005 Feb; 44(6):1768-79. PubMed ID: 15697202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay.
    Loschwitz J; Jäckering A; Keutmann M; Olagunju M; Eberle RJ; Coronado MA; Olubiyi OO; Strodel B
    Bioorg Chem; 2021 Jun; 111():104862. PubMed ID: 33862474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus.
    Qiao Z; Wei N; Jin L; Zhang H; Luo J; Zhang Y; Wang K
    Bioorg Chem; 2021 Dec; 117():105455. PubMed ID: 34740055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.
    Kneller DW; Phillips G; Weiss KL; Pant S; Zhang Q; O'Neill HM; Coates L; Kovalevsky A
    J Biol Chem; 2020 Dec; 295(50):17365-17373. PubMed ID: 33060199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
    Wang W; Liang TC
    Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.